P.A.W. Capital’s Cytosorbents Corp CTSO Stock Holding History

P.A.W. Capital’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$129K	–	64
2018 Q3	$129K	Buy	+10,000	New	+$125K	0.14%	64

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

P.A.W. Capital's CTSO Position: Q4 2018 in Review

P.A.W. Capital sold out of Cytosorbents Corp (CTSO) in Q4 2018, closing a stake of 10,000 shares — an estimated $129K sold.

P.A.W. Capital first reported a position in CTSO in Q3 2018 and held it in 1 quarter. The position peaked at $129K in Q3 2018. 85 funds tracked by Wall St. Rank hold CTSO as of Q4 2018.

P.A.W. Capital reported no remaining Cytosorbents Corp position as of Q4 2018 after selling out during the quarter.
P.A.W. Capital sold 10,000 Cytosorbents Corp shares in Q4 2018, an estimated $129K.
P.A.W. Capital first reported a position in Cytosorbents Corp in Q3 2018 and held it in 1 quarter.
P.A.W. Capital's Cytosorbents Corp position peaked at $129K in Q3 2018.
85 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2018.

Based on P.A.W. Capital's 13F filing for Q4 2018, filed 6 Feb 2019.